Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis

Xu,Lin; Wang,Zhu; Li,Xiao-Fei; He,Xia; Guan,Lin-Lin; Tuo,Jiu-Ling; Wang,Yang; Luo,Yanfen; Zhong,Hui-Ling; Qiu,Shao-Peng; Cao,Kai-Yuan

doi:10.3892/or.2013.2656

Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis

Authors:
- Lin Xu
- Zhu Wang
- Xiao-Fei Li
- Xia He
- Lin-Lin Guan
- Jiu-Ling Tuo
- Yang Wang
- Yanfen Luo
- Hui-Ling Zhong
- Shao-Peng Qiu
- Kai-Yuan Cao
View Affiliations

Affiliations: Department of Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, P.R. China, Department of Urology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, P.R. China, Research Center for Clinical Laboratory Standard, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, P.R. China
Published online on: August 5, 2013 https://doi.org/10.3892/or.2013.2656
Pages: 1920-1928

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tumor metastasis is one of the causes for the high mortality rate of prostate cancer (PCa) patients, yet the molecular mechanisms of PCa metastasis are not fully understood. In our previous studies, we found that PSMA suppresses the metastasis of PCa, yet the underlying mechanism remains unknown. To identify the genes related to tumor metastasis possibly regulated by PSMA, we performed tumor metastasis PCR array assay to analyze the differentially expressed tumor metastasis-related genes. Eighty-four tumor metastasis related genes were screened in si-PSMA LNCap cells (PSMA silenced by siRNA)/LNCap cells and in PC-3/LNcap cells, respectively. Expression levels of possible related genes were verified by real-time PCR in 4 prostate cancer cell lines (LNCap, 22RV1, PC-3 and DU145) and in 85 clinical samples (12 normal, 26 benign prostatic hypertrophy and 47 prostate cancer tissues). The results showed that 10 genes (including CDH6 and CXCL12) were upregulated and 4 genes (CCL7, ITGB3, MDM2 and MMP2) were downregulated in the si-PSMA LNCap cells. There were 41 genes significantly upregulated and 15 genes downregulated in PC-3 cells when compared with LNCap cells. Eight common genes were found in both the si-PSMA and PSMA(-) groups. CDH6, MMP3, MTSS1 were further identified as PSMA-related genes in the prostate cancer cell lines and clinical samples, and their expression showed a negative correlation with the stage of prostate cancer (P<0.0001) and PSMA level (P<0.05) in clinical samples, indicating their possible involvement in PSMA-related PCa metastasis regulation. These findings may provide insights into the mechanism involved in the suppression of PCa metastasis by PSMA and its possible interacting proteins, and may provide clues for further exploration of the molecular mechanism of PCa metastasis.

View Figures

View References

1	Chang SS: Overview of prostate-specific membrane antigen. Rev Urol. 6(Suppl 10): S13–S18. 2004.PubMed/NCBI
2	Kypta R, Unda M and Carracedo A: Is the bench getting closer to the bedside in the war on cancer? A quick look at prostate cancer. Front Endocrinol. 3:532012. View Article : Google Scholar : PubMed/NCBI
3	Nelson WG, De Marzo AM and Isaacs WB: Prostate cancer. N Engl J Med. 349:366–381. 2003. View Article : Google Scholar
4	Paller CJ, Carducci MA and Philips GK: Management of bone metastases in refractory prostate cancer - role of denosumab. Clin Interv Aging. 7:363–372. 2012. View Article : Google Scholar : PubMed/NCBI
5	Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: Cancer statistics. CA Cancer J Clin. 54:8–29. 2004.
6	Germain A, Richardson R, Moul DE, Mammen O, Haas G, Forman SD, Rode N, Begley A and Nofzinger EA: Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances in US Military Veterans. J Psychosom Res. 72:89–96. 2012. View Article : Google Scholar : PubMed/NCBI
7	Schroder FH: Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms. Eur Urol. 53:1129–1137. 2008. View Article : Google Scholar
8	Kasper S and Cookson MS: Mechanisms leading to the development of hormone-resistant prostate cancer. Urol Clin North Am. 33:201–210. vii2006. View Article : Google Scholar : PubMed/NCBI
9	Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B and Heston WD: Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res. 2:1445–1451. 1996.PubMed/NCBI
10	Robinson MB, Blakely RD, Couto R and Coyle JT: Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem. 262:14498–14506. 1987.PubMed/NCBI
11	Cao KY, Mao XP, Wang DH, Xu L, Yuan GQ, Dai SQ, Zheng BJ and Qiu SP: High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen. Prostate. 67:1791–1800. 2007. View Article : Google Scholar : PubMed/NCBI
12	Cao KY, Xu L, Zhang DM, Zhang XM, Zhang T, He X, Wang Z, Feng FS, Qiu SP and Shen GX: New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells. Int J Oncol. 40:1977–1985. 2012.PubMed/NCBI
13	Ghosh A and Heston WD: Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer. J Cell Biochem. 91:528–539. 2004. View Article : Google Scholar
14	Frigerio B, Fracasso G, Luison E, Cingarlini S, Mortarino M, Coliva A, Seregni E, Bombardieri E, Zuccolotto G, Rosato A, Colombatti M, Canevari S and Figini M: A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer. Eur J Cancer. pii: S0959-8049(13)00087-7. View Article : Google Scholar : 2013. View Article : Google Scholar
15	Zhao LY, Mao XP, Chao KY, Guo SJ and Qiu SP: Prostate-specific membrane antigen can promote in vivo osseous metastasis of prostate cancer cells in mice. Braz J Med Biol Res. 45:737–745. 2012. View Article : Google Scholar : PubMed/NCBI
16	Mannweiler S, Amersdorfer P, Trajanoski S, Terrett JA, King D and Mehes G: Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis. Pathol Oncol Res. 15:167–172. 2009. View Article : Google Scholar : PubMed/NCBI
17	Ghosh A, Wang X, Klein E and Heston WD: Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness. Cancer Res. 65:727–731. 2005.PubMed/NCBI
18	Xie BX, Zhang H, Wang J, Pang B, Wu RQ, Qian XL, Yu L, Li SH, Shi QG, Huang CF and Zhou JG: Analysis of differentially expressed genes in LNCaP prostate cancer progression model. J Androl. 32:170–182. 2010.PubMed/NCBI
19	Wang G, Firoz EF, Rose A, Blochin E, Christos P, Pollens D, Mazumdar M, Gerald W, Oddoux C, Lee P and Osman I: MDM2 expression and regulation in prostate cancer racial disparity. Int J Clin Exp Pathol. 2:353–360. 2009.PubMed/NCBI
20	Kohn EC: Invasion and metastasis: biology and clinical potential. Pharmacol Ther. 52:235–244. 1991. View Article : Google Scholar : PubMed/NCBI
21	Duffy MJ, McGowan PM and Gallagher WM: Cancer invasion and metastasis: changing views. J Pathol. 214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
22	Kong L, Yuan Q, Zhu H, Li Y, Guo Q, Wang Q, Bi X and Gao X: The suppression of prostate LNCaP cancer cells growth by Selenium nanoparticles through Akt/Mdm2/AR controlled apoptosis. Biomaterials. 32:6515–6522. 2011. View Article : Google Scholar : PubMed/NCBI
23	Roomi MW, Monterrey JC, Kalinovsky T, Rath M and Niedzwiecki A: Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: a correlation study. Exp Oncol. 32:243–248. 2011.PubMed/NCBI
24	Loberg RD, Neeley CK, Adam-Day LL, Fridman Y, St John LN, Nixdorf S, Jackson P, Kalikin LM and Pienta KJ: Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology. Int J Oncol. 26:1699–1705. 2005.PubMed/NCBI
25	Inoue T, Inoue YU, Asami J, Izumi H, Nakamura S and Krumlauf R: Analysis of mouse Cdh6 gene regulation by transgenesis of modified bacterial artificial chromosomes. Dev Biol. 315:506–520. 2008. View Article : Google Scholar : PubMed/NCBI
26	Mendes O, Kim HT and Stoica G: Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis. 22:237–246. 2005. View Article : Google Scholar : PubMed/NCBI
27	Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ and Lin SR: MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep. 22:1119–1127. 2009.PubMed/NCBI
28	Wang W, Wu W, Desai T, Ward DC and Kaufman SJ: Localization of the alpha 7 integrin gene (ITGA7) on human chromosome 12q13: clustering of integrin and Hox genes implies parallel evolution of these gene families. Genomics. 26:568–570. 1995. View Article : Google Scholar : PubMed/NCBI
29	Samson T, Smyth N, Janetzky S, Wendler O, Müller JM, Schüle R, von der Mark H, von der Mark K and Wixler V: The LIM-only proteins FHL₂ and FHL₃ interact with α- and β-subunits of the muscle α₇β₁ integrin receptor. J Biol Chem. 279:28641–28652. 2004.PubMed/NCBI
30	Zhu ZH, Yu YP, Zheng ZL, Song Y, Xiang GS, Nelson J, Michalopoulos G and Luo JH: Integrin alpha 7 interacts with high temperature requirement A2 (HtrA2) to induce prostate cancer cell death. Am J Pathol. 177:1176–1186. 2010. View Article : Google Scholar : PubMed/NCBI
31	Mazzoccoli G, Sothern RB, Pazienza V, Piepoli A, Muscarella LA, Giuliani F and Tarquini R: Circadian aspects of growth hormone-insulin-like growth factor axis function in patients with lung cancer. Clin Lung Cancer. 13:68–74. 2011. View Article : Google Scholar : PubMed/NCBI
32	Montagnani Marelli M, Moretti RM, Procacci P, Motta M and Limonta P: Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the α_vβ₃ integrin and PI3-K/Akt signaling. Int J Oncol. 28:723–730. 2006.PubMed/NCBI
33	Nickerson T, Chang F, Lorimer D, Smeekens SP, Sawyers CL and Pollak M: In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Cancer Res. 61:6276–6280. 2001.PubMed/NCBI
34	Uygur B and Wu WS: SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer. 10:1392011. View Article : Google Scholar : PubMed/NCBI